Medline (NASDAQ:MDLN) Price Target Raised to $60.00 at Tigress Financial

Medline (NASDAQ:MDLN) had its target price upped by Tigress Financial from $55.00 to $60.00 in a research report report published on Monday,Benzinga reports. They currently have a buy rating on the stock.

Several other equities analysts also recently weighed in on MDLN. BNP Paribas Exane assumed coverage on Medline in a research report on Monday, January 12th. They set a “neutral” rating and a $38.00 target price on the stock. Robert W. Baird initiated coverage on Medline in a report on Monday, January 12th. They issued an “outperform” rating and a $48.00 price target for the company. Wolfe Research assumed coverage on shares of Medline in a research note on Monday, January 12th. They set an “outperform” rating and a $47.00 price objective for the company. Bank of America assumed coverage on shares of Medline in a report on Monday, January 12th. They set a “buy” rating and a $50.00 price objective on the stock. Finally, Stifel Nicolaus set a $55.00 target price on shares of Medline in a research report on Wednesday, February 25th. Two analysts have rated the stock with a Strong Buy rating, twenty-one have given a Buy rating and five have given a Hold rating to the company’s stock. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus target price of $50.69.

Medline Price Performance

Shares of MDLN opened at $43.41 on Monday. Medline has a fifty-two week low of $34.89 and a fifty-two week high of $50.88. The company has a fifty day simple moving average of $44.59.

Medline (NASDAQ:MDLN) last posted its quarterly earnings data on Wednesday, February 25th. The company reported ($0.01) earnings per share (EPS) for the quarter, missing the consensus estimate of $0.24 by ($0.25). The firm had revenue of $7.79 billion during the quarter, compared to analyst estimates of $7.52 billion. The business’s revenue was up 14.8% on a year-over-year basis.

Insiders Place Their Bets

In other news, Director Charles N. Mills acquired 2,579,310 shares of the business’s stock in a transaction dated Thursday, December 18th. The shares were bought at an average cost of $29.00 per share, for a total transaction of $74,799,990.00. Following the acquisition, the director directly owned 2,441,379 shares in the company, valued at $70,799,991. This trade represents a -1,870.00% increase in their position. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Andrew J. Mills bought 2,586,206 shares of the company’s stock in a transaction that occurred on Thursday, December 18th. The shares were acquired at an average cost of $29.00 per share, with a total value of $74,999,974.00. Following the transaction, the director owned 2,586,206 shares in the company, valued at approximately $74,999,974. This represents a ∞ increase in their position. The SEC filing for this purchase provides additional information.

Institutional Investors Weigh In On Medline

Large investors have recently made changes to their positions in the business. Sound Income Strategies LLC purchased a new stake in Medline during the 4th quarter worth $25,000. Entrust Financial LLC acquired a new position in Medline in the 4th quarter worth $26,000. NBC Securities Inc. purchased a new position in Medline in the 4th quarter valued at about $28,000. Global Retirement Partners LLC acquired a new stake in shares of Medline during the fourth quarter valued at about $31,000. Finally, North Star Investment Management Corp. acquired a new stake in shares of Medline during the fourth quarter valued at about $36,000.

About Medline

Medline (NASDAQ: MDLN) is a healthcare products and services company that manufactures, sources and distributes a wide range of medical supplies and equipment for healthcare providers. Its product portfolio spans clinical consumables and personal protective equipment, surgical and procedural supplies, wound care and incontinence products, diagnostic and laboratory supplies, and select durable medical equipment. Medline supports care settings that include hospitals, health systems, long-term care facilities, ambulatory clinics and home health providers.

In addition to product manufacturing and distribution, Medline provides supply‑chain and logistics services designed to help healthcare customers manage inventory, reduce costs and streamline operations.